BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18026141)

  • 1. Protein kinase CK2 interacts with the splicing factor hPrp3p.
    Lehnert S; Götz C; Kartarius S; Schäfer B; Montenarh M
    Oncogene; 2008 Apr; 27(17):2390-400. PubMed ID: 18026141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the individual subunits of protein kinase CK2 and of hPrp3p to the splicing process.
    Dörr J; Kartarius S; Götz C; Montenarh M
    Mol Cell Biochem; 2008 Sep; 316(1-2):187-93. PubMed ID: 18553058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.
    Tapia JC; Bolanos-Garcia VM; Sayed M; Allende CC; Allende JE
    J Cell Biochem; 2004 Apr; 91(5):865-79. PubMed ID: 15034923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
    Salvi M; Sarno S; Marin O; Meggio F; Itarte E; Pinna LA
    FEBS Lett; 2006 Jul; 580(16):3948-52. PubMed ID: 16806200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of human genes encoding Hprp3p and Hprp4p, interacting components of the spliceosome.
    Wang A; Forman-Kay J; Luo Y; Luo M; Chow YH; Plumb J; Friesen JD; Tsui LC; Heng HH; Woolford JL; Hu J
    Hum Mol Genet; 1997 Nov; 6(12):2117-26. PubMed ID: 9328476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide.
    Poletto G; Vilardell J; Marin O; Pagano MA; Cozza G; Sarno S; Falqués A; Itarte E; Pinna LA; Meggio F
    Biochemistry; 2008 Aug; 47(32):8317-25. PubMed ID: 18636746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
    Lebrin F; Chambaz EM; Bianchini L
    Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human U4/U6 snRNP recycling factor p110: mutational analysis reveals the function of the tetratricopeptide repeat domain in recycling.
    Medenbach J; Schreiner S; Liu S; Lührmann R; Bindereif A
    Mol Cell Biol; 2004 Sep; 24(17):7392-401. PubMed ID: 15314151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promiscuous subunit interactions: a possible mechanism for the regulation of protein kinase CK2.
    Allende CC; Allende JE
    J Cell Biochem Suppl; 1998; 30-31():129-36. PubMed ID: 9893264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction sites between catalytic and regulatory subunits in human protein kinase CK2 holoenzymes as indicated by chemical cross-linking and immunological investigations.
    Krehan A; Lorenz P; Plana-Coll M; Pyerin W
    Biochemistry; 1996 Apr; 35(15):4966-75. PubMed ID: 8664289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
    Vilk G; Weber JE; Turowec JP; Duncan JS; Wu C; Derksen DR; Zien P; Sarno S; Donella-Deana A; Lajoie G; Pinna LA; Li SS; Litchfield DW
    Cell Signal; 2008 Nov; 20(11):1942-51. PubMed ID: 18662771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human U5 snRNP 52K protein (CD2BP2) interacts with U5-102K (hPrp6), a U4/U6.U5 tri-snRNP bridging protein, but dissociates upon tri-snRNP formation.
    Laggerbauer B; Liu S; Makarov E; Vornlocher HP; Makarova O; Ingelfinger D; Achsel T; Lührmann R
    RNA; 2005 May; 11(5):598-608. PubMed ID: 15840814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localization of epitope-tagged protein kinase CK2.
    Penner CG; Wang Z; Litchfield DW
    J Cell Biochem; 1997 Mar; 64(4):525-37. PubMed ID: 9093902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How druggable is protein kinase CK2?
    Cozza G; Bortolato A; Moro S
    Med Res Rev; 2010 May; 30(3):419-62. PubMed ID: 19526464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of protein kinase CK2 as oncological target.
    Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
    Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the InsP6-dependent interaction between CK2 and Nopp140.
    Lee WK; Lee SY; Kim WI; Rho YH; Bae YS; Lee C; Kim IY; Yu YG
    Biochem Biophys Res Commun; 2008 Nov; 376(2):439-44. PubMed ID: 18790693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A historical view of protein kinase CK2.
    Pinna LA
    Cell Mol Biol Res; 1994; 40(5-6):383-90. PubMed ID: 7735312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in the splicing factor Hprp3p linked to retinitis pigmentosa impairs interactions within the U4/U6 snRNP complex.
    Gonzalez-Santos JM; Cao H; Duan RC; Hu J
    Hum Mol Genet; 2008 Jan; 17(2):225-39. PubMed ID: 17932117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous nuclear ribonucleoprotein A2 interacts with protein kinase CK2.
    Pancetti F; Bosser R; Krehan A; Pyerin W; Itarte E; Bachs O
    Biochem Biophys Res Commun; 1999 Jun; 260(1):17-22. PubMed ID: 10381337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of genes encoding protein kinase CK2 subunits in the plant cell cycle.
    Espunya MC; López-Giráldez T; Hernan I; Carballo M; Martínez MC
    J Exp Bot; 2005 Dec; 56(422):3183-92. PubMed ID: 16263904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.